A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight (REDEFINE 2)
Primary Purpose
Overweight, Obesity, Type 2 Diabetes Mellitus
Status
Recruiting
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Cagrilintide
Semaglutide
Placebo cagrilintide
Placebo semaglutide
Sponsored by
About this trial
This is an interventional treatment trial for Overweight
Eligibility Criteria
Inclusion Criteria:
- Male or female
- Age above or equal to 18 years at the time of signing informed consent
- BMI greather than or equal to 27.0 kg/m^2
- Diagnosed with type 2 diabetes mellitus greater than or equal to 180 days before screening
- Treatment with either lifestyle intervention, or treatment with 1-3 marketed oral antidiabetic drugs (OAD)s (metformin, α-glucosidase inhibitors (AGI), glinides, sodium-glucose co-transporter 2 inhibitor (SGLT2i), thiazolidinediones, or sulphonylureas (SU)s as a single agent or in combination) according to local label
- Treatment with oral antidiabetic drugs should be stable (same drug(s), dose and dosing frequency) for at least 90 days before screening
- HbA1c 7%-10% (53-86 mmol/mol) (both inclusive) as measured by the central laboratory at screening
Exclusion Criteria:
- Clinically significant or severe hypoglycaemia within 6 months before screening or history of hypoglycaemia unawareness
- Renal impairment with estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m^2, as measured by the central laboratory at screening
- Uncontrolled and potentially unstable diabetic retinopathy or maculopathy. Verified by a fundus examination performed within 90 days before screening or in the period between screening and randomisation. Pharmacological pupil-dilation is a requirement unless using a digital fundus photography camera specified for non-dilated examination.
Sites / Locations
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational SiteRecruiting
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational SiteRecruiting
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational SiteRecruiting
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
- Novo Nordisk Investigational Site
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
CagriSema
Placebo
Arm Description
Cagrilintide + semaglutide once weekly
Placebo cagrilintide + semaglutide once weekly
Outcomes
Primary Outcome Measures
Relative change in body weight
Measured in %
Achievement of greater than or equal to 5% weight reduction
Count of participant
Secondary Outcome Measures
Achievement of ≥ 20% weight reduction
Count of participant
Relative change in body weight
Measured in %
Change in waist circumference
Measured in cm
Change in Glycated Haemoglobin (HbA1c)
%-points
Change in Systolic Blood Pressure (SBP)
Measured in mmHg
Change in Quality Of Life-Lite Clinical Trials Version (IWQOL-Lite-CT) Physical Function score
Score points
Change in Short Form-36 Version 2.0 (SF-36v2) Physical Functioning score
Score points
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05394519
Brief Title
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
Acronym
REDEFINE 2
Official Title
Efficacy and Safety of Cagrilintide s.c. 2.4 mg in Combination With Semaglutide s.c. 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity and Type 2 Diabetes
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 1, 2023 (Actual)
Primary Completion Date
December 11, 2024 (Anticipated)
Study Completion Date
January 29, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Novo Nordisk A/S
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will look at how well the new medicine CagriSema helps people living with excess body weight and type 2 diabetes losing weight. Participants will either get CagriSema or a dummy medicine. Which treatment they get is decided by chance.
The study will last for about 1½ years. Women cannot take part if pregnant, breast-feeding or plan to get pregnant during the study period.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight, Obesity, Type 2 Diabetes Mellitus
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
1200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
CagriSema
Arm Type
Experimental
Arm Description
Cagrilintide + semaglutide once weekly
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo cagrilintide + semaglutide once weekly
Intervention Type
Drug
Intervention Name(s)
Cagrilintide
Intervention Description
Cagrilintide administered subcutaneously (s.c., under the skin) once-weekly
Intervention Type
Drug
Intervention Name(s)
Semaglutide
Intervention Description
Semaglutide administered subcutaneously (s.c., under the skin) once-weekly
Intervention Type
Drug
Intervention Name(s)
Placebo cagrilintide
Intervention Description
Placebo cagrilintide administered subcutaneously (s.c., under the skin) once-weekly
Intervention Type
Drug
Intervention Name(s)
Placebo semaglutide
Intervention Description
Placebo semaglutide administered subcutaneously (s.c., under the skin) once-weekly
Primary Outcome Measure Information:
Title
Relative change in body weight
Description
Measured in %
Time Frame
From baseline (week 0) to end of treatment (week 68)
Title
Achievement of greater than or equal to 5% weight reduction
Description
Count of participant
Time Frame
From baseline (week 0) to end of treatment (week 68)
Secondary Outcome Measure Information:
Title
Achievement of ≥ 20% weight reduction
Description
Count of participant
Time Frame
From baseline (week 0) to end of treatment (week 68)
Title
Relative change in body weight
Description
Measured in %
Time Frame
From baseline (week 0) to week 20
Title
Change in waist circumference
Description
Measured in cm
Time Frame
From baseline (week 0) to end of treatment (week 68)
Title
Change in Glycated Haemoglobin (HbA1c)
Description
%-points
Time Frame
From baseline (week 0) to end of treatment (week 68)
Title
Change in Systolic Blood Pressure (SBP)
Description
Measured in mmHg
Time Frame
From baseline (week 0) to end of treatment (week 68)
Title
Change in Quality Of Life-Lite Clinical Trials Version (IWQOL-Lite-CT) Physical Function score
Description
Score points
Time Frame
From baseline (week 0) to end of treatment (week 68)
Title
Change in Short Form-36 Version 2.0 (SF-36v2) Physical Functioning score
Description
Score points
Time Frame
From baseline (week 0) to end of treatment (week 68)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female
Age above or equal to 18 years at the time of signing informed consent
BMI greather than or equal to 27.0 kg/m^2
Diagnosed with type 2 diabetes mellitus greater than or equal to 180 days before screening
Treatment with either lifestyle intervention, or treatment with 1-3 marketed oral antidiabetic drugs (OAD)s (metformin, α-glucosidase inhibitors (AGI), glinides, sodium-glucose co-transporter 2 inhibitor (SGLT2i), thiazolidinediones, or sulphonylureas (SU)s as a single agent or in combination) according to local label
Treatment with oral antidiabetic drugs should be stable (same drug(s), dose and dosing frequency) for at least 90 days before screening
HbA1c 7%-10% (53-86 mmol/mol) (both inclusive) as measured by the central laboratory at screening
Exclusion Criteria:
Clinically significant or severe hypoglycaemia within 6 months before screening or history of hypoglycaemia unawareness
Renal impairment with estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m^2, as measured by the central laboratory at screening
Uncontrolled and potentially unstable diabetic retinopathy or maculopathy. Verified by a fundus examination performed within 90 days before screening or in the period between screening and randomisation. Pharmacological pupil-dilation is a requirement unless using a digital fundus photography camera specified for non-dilated examination.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Novo Nordisk
Phone
(+1) 866-867-7178
Email
clinicaltrials@novonordisk.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Clinical Transparency (dept. 2834)
Organizational Affiliation
Novo Nordisk A/S
Official's Role
Study Director
Facility Information:
Facility Name
Novo Nordisk Investigational Site
City
Concord
State/Province
California
ZIP/Postal Code
94520
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Escondido
State/Province
California
ZIP/Postal Code
92025
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Escondido
State/Province
California
ZIP/Postal Code
92025
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Fullerton
State/Province
California
ZIP/Postal Code
92835
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Huntington Beach
State/Province
California
ZIP/Postal Code
92648
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lincoln
State/Province
California
ZIP/Postal Code
95648
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lincoln
State/Province
California
ZIP/Postal Code
95648
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Palm Springs
State/Province
California
ZIP/Postal Code
92262
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Palm Springs
State/Province
California
ZIP/Postal Code
92262
Country
United States
Individual Site Status
Recruiting
Facility Name
Novo Nordisk Investigational Site
City
Walnut Creek
State/Province
California
ZIP/Postal Code
94598
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Golden
State/Province
Colorado
ZIP/Postal Code
80401
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33765
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Fleming Island
State/Province
Florida
ZIP/Postal Code
32003
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32216
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ocala
State/Province
Florida
ZIP/Postal Code
34470
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Orlando
State/Province
Florida
ZIP/Postal Code
32804
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Orlando
State/Province
Florida
ZIP/Postal Code
32825
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Oviedo
State/Province
Florida
ZIP/Postal Code
32765
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Roswell
State/Province
Georgia
ZIP/Postal Code
30076
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Roswell
State/Province
Georgia
ZIP/Postal Code
30076
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Honolulu
State/Province
Hawaii
ZIP/Postal Code
96814
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60607
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
West Des Moines
State/Province
Iowa
ZIP/Postal Code
50265
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Topeka
State/Province
Kansas
ZIP/Postal Code
66606-2806
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40213
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70808
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Buckley
State/Province
Michigan
ZIP/Postal Code
49620
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55416
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saint Peters
State/Province
Missouri
ZIP/Postal Code
63303
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Butte
State/Province
Montana
ZIP/Postal Code
59701
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Albany
State/Province
New York
ZIP/Postal Code
12203
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
West Seneca
State/Province
New York
ZIP/Postal Code
14224
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Westfield
State/Province
New York
ZIP/Postal Code
14787
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27408
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Simpsonville
State/Province
South Carolina
ZIP/Postal Code
29681-1538
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Simpsonville
State/Province
South Carolina
ZIP/Postal Code
29681-1538
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kingsport
State/Province
Tennessee
ZIP/Postal Code
37660
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kingsport
State/Province
Tennessee
ZIP/Postal Code
37660
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Amarillo
State/Province
Texas
ZIP/Postal Code
79106
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Austin
State/Province
Texas
ZIP/Postal Code
78731
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Austin
State/Province
Texas
ZIP/Postal Code
78749
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dallas
State/Province
Texas
ZIP/Postal Code
75230
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390-9302
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77079
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Longview
State/Province
Texas
ZIP/Postal Code
75605
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Shavano Park
State/Province
Texas
ZIP/Postal Code
78231
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Shavano Park
State/Province
Texas
ZIP/Postal Code
78231
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saint George
State/Province
Utah
ZIP/Postal Code
84790
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23294
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Winchester
State/Province
Virginia
ZIP/Postal Code
22601-3834
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Winchester
State/Province
Virginia
ZIP/Postal Code
22601
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Olympia
State/Province
Washington
ZIP/Postal Code
98502
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Graz
ZIP/Postal Code
8036
Country
Austria
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Linz
ZIP/Postal Code
4021
Country
Austria
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saint Stefan
ZIP/Postal Code
8511
Country
Austria
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wien
ZIP/Postal Code
1030
Country
Austria
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wien
ZIP/Postal Code
1090
Country
Austria
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wien
ZIP/Postal Code
A 1190
Country
Austria
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2H 2G4
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2V 4J2
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Victoria
State/Province
British Columbia
ZIP/Postal Code
V8V 4A1
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mount Pearl
State/Province
Newfoundland and Labrador
ZIP/Postal Code
A1N 1W7
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Brampton
State/Province
Ontario
ZIP/Postal Code
L6S 0C6
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Etobicoke
State/Province
Ontario
ZIP/Postal Code
M9R 4E1
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8L 5G8
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
London
State/Province
Ontario
ZIP/Postal Code
N5W 6A2
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nepean
State/Province
Ontario
ZIP/Postal Code
K2J 0V2
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M6G 1M2
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H4N 2W2
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saint-Laurent
State/Province
Quebec
ZIP/Postal Code
H4T 1Z9
Country
Canada
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bad Mergentheim
ZIP/Postal Code
97980
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Elsterwerda
ZIP/Postal Code
04910
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Essen
ZIP/Postal Code
45136
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Freiburg
ZIP/Postal Code
79106
Country
Germany
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Hamburg
ZIP/Postal Code
22607
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Leipzig
ZIP/Postal Code
04107
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Münster
ZIP/Postal Code
48145
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Saint Ingbert-Oberwürzbach
ZIP/Postal Code
66386
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Stuttgart
ZIP/Postal Code
70378
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wangen
ZIP/Postal Code
88239
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Szeged
State/Province
Csongrád-Csanád
ZIP/Postal Code
H-6725
Country
Hungary
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Debrecen
State/Province
Hajdu-Bihar
ZIP/Postal Code
4032
Country
Hungary
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Szolnok
State/Province
Jász-Nagykun-Szolnok
ZIP/Postal Code
5004
Country
Hungary
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Komárom
State/Province
Komárom-Esztergom
ZIP/Postal Code
2900
Country
Hungary
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Budapest
ZIP/Postal Code
1033
Country
Hungary
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Budapest
ZIP/Postal Code
1042
Country
Hungary
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Budapest
ZIP/Postal Code
1042
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Budapest
ZIP/Postal Code
1106
Country
Hungary
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Budapest
ZIP/Postal Code
1106
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Komárom
ZIP/Postal Code
2900
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Szolnok
ZIP/Postal Code
5004
Country
Hungary
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ahmedabad
State/Province
Gujarat
ZIP/Postal Code
380006
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ahmedabad
State/Province
Gujarat
ZIP/Postal Code
380006
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangalore
State/Province
Karnataka
ZIP/Postal Code
560054
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kozhikode
State/Province
Kerala
ZIP/Postal Code
673008
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Thiruvananthapuram
State/Province
Kerala
ZIP/Postal Code
695031
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kolhapur
State/Province
Maharashtra
ZIP/Postal Code
416008
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kolhapur
State/Province
Maharashtra
ZIP/Postal Code
416008
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mumbai
State/Province
Maharashtra
ZIP/Postal Code
400008
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mumbai
State/Province
Maharashtra
ZIP/Postal Code
400008
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mumbai
State/Province
Maharashtra
ZIP/Postal Code
400012
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Mumbai
State/Province
Maharashtra
ZIP/Postal Code
400012
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nagpur
State/Province
Maharashtra
ZIP/Postal Code
440010
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pune
State/Province
Maharashtra
ZIP/Postal Code
411013
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Pune
State/Province
Maharashtra
ZIP/Postal Code
411013
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ansari Nagar
State/Province
New Delhi
ZIP/Postal Code
110029
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ansari Nagar
State/Province
New Delhi
ZIP/Postal Code
110029
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chandigarh
State/Province
Punjab
ZIP/Postal Code
160012
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chandigarh
State/Province
Punjab
ZIP/Postal Code
160012
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jaipur
State/Province
Rajasthan
ZIP/Postal Code
302004
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Jaipur
State/Province
Rajasthan
ZIP/Postal Code
302004
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chennai
State/Province
Tamil Nadu
ZIP/Postal Code
600006
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chennai
State/Province
Tamil Nadu
ZIP/Postal Code
600086
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hyderabad
State/Province
Telangana
ZIP/Postal Code
500004
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kolkata
State/Province
West Bengal
ZIP/Postal Code
700054
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kolkata
State/Province
West Bengal
ZIP/Postal Code
700054
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nagpur
ZIP/Postal Code
440010
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
New Delhi
ZIP/Postal Code
110001
Country
India
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
New Delhi
ZIP/Postal Code
110001
Country
India
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Galway
State/Province
Connaght
ZIP/Postal Code
H91 YR71
Country
Ireland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dublin
State/Province
Leinster
ZIP/Postal Code
D04 T6F4
Country
Ireland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dublin
State/Province
Leinster
ZIP/Postal Code
D08 A978
Country
Ireland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dublin
State/Province
Leinster
ZIP/Postal Code
DUBLIN 15
Country
Ireland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Dublin
State/Province
Leinster
ZIP/Postal Code
DUBLIN 7
Country
Ireland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Aichi
ZIP/Postal Code
468-0009
Country
Japan
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chiba
ZIP/Postal Code
261-0004
Country
Japan
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ibaraki
ZIP/Postal Code
311-0113
Country
Japan
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Osaka
ZIP/Postal Code
530-0001
Country
Japan
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Osaka
ZIP/Postal Code
565-0871
Country
Japan
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Osaka
ZIP/Postal Code
569-1045
Country
Japan
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kota Bharu
State/Province
Kelantan
ZIP/Postal Code
16150
Country
Malaysia
Individual Site Status
Withdrawn
Facility Name
Novo Nordisk Investigational Site
City
Cheras
State/Province
Kuala Lumpur
ZIP/Postal Code
56000
Country
Malaysia
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sarawak
State/Province
Miri
ZIP/Postal Code
98000
Country
Malaysia
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Seri Manjung
State/Province
Perak
ZIP/Postal Code
32040
Country
Malaysia
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kuching
State/Province
Sarawak
ZIP/Postal Code
93586
Country
Malaysia
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ampang, Selangor
State/Province
Selangor
ZIP/Postal Code
68000
Country
Malaysia
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sungai Buloh
State/Province
Selangor
ZIP/Postal Code
47000
Country
Malaysia
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Putrajaya
State/Province
Wilayah Persekutuan Putrajaya
ZIP/Postal Code
62250
Country
Malaysia
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Melaka
ZIP/Postal Code
75400
Country
Malaysia
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Seremban
ZIP/Postal Code
70300
Country
Malaysia
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Legnica
State/Province
Dolnośląskie
ZIP/Postal Code
59-220
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bygdoszcz
State/Province
Kuyavian-Pomeranian Voivodeship
ZIP/Postal Code
85-796
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lublin
State/Province
Lubelskie Voivodeship
ZIP/Postal Code
20-333
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Warszawa
State/Province
Mazovian Voivodeship
ZIP/Postal Code
02-117
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Warszawa
State/Province
Mazovian
ZIP/Postal Code
02-117
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Warszawa
State/Province
Mazowieckie
ZIP/Postal Code
00-416
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Warszawa
State/Province
Mazowieckie
ZIP/Postal Code
02-798
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kraków
State/Province
Małopolskie
ZIP/Postal Code
30-721
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bialystok
State/Province
Podlaskie Voivodeship
ZIP/Postal Code
15-276
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bialystok
State/Province
Podlaskie Voivodeship
ZIP/Postal Code
15-281
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bialystok
State/Province
Podlaskie
ZIP/Postal Code
15-281
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Gdansk
State/Province
Pomorskie
ZIP/Postal Code
80-952
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Katowice
State/Province
Slaskie Voivodeship
ZIP/Postal Code
40-772
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Elblag
State/Province
Warmińsko-Mazurskie
ZIP/Postal Code
82-300
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Poznan
State/Province
Wielkopolskie Voivodeship
ZIP/Postal Code
60-589
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Poznan
State/Province
Wielkopolskie
ZIP/Postal Code
60-589
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bialystok
ZIP/Postal Code
15-276
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bygdoszcz
ZIP/Postal Code
85-796
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Gdansk
ZIP/Postal Code
80-952
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Katowice
ZIP/Postal Code
40-001
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Kraków
ZIP/Postal Code
30-721
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Lublin
ZIP/Postal Code
20-333
Country
Poland
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Piotrków Trybunalski
State/Province
Łódzkie
ZIP/Postal Code
97-300
Country
Poland
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Ponce
ZIP/Postal Code
00716
Country
Puerto Rico
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkoknoi, Bangkok
State/Province
Bangkok
ZIP/Postal Code
10700
Country
Thailand
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Muang
State/Province
Khon Kaen
ZIP/Postal Code
40002
Country
Thailand
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Klong Luang, Pathumthani
State/Province
Pathumthani
ZIP/Postal Code
12120
Country
Thailand
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10330
Country
Thailand
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10330
Country
Thailand
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10400
Country
Thailand
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bangkok
ZIP/Postal Code
10400
Country
Thailand
Individual Site Status
Not yet recruiting
Facility Name
Novo Nordisk Investigational Site
City
Addlestone
State/Province
Surrey
ZIP/Postal Code
KT15 2BH
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Antrim
ZIP/Postal Code
BT42 2RL
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Blackpool
ZIP/Postal Code
FY3 7EN
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bradford-on-Avon
ZIP/Postal Code
BA15 1DQ
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Bristol
ZIP/Postal Code
BS10 5NB
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Chippenham
ZIP/Postal Code
SN14 6GT
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Harrogate, North Yorkshire
ZIP/Postal Code
HG2 7SX
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Hounslow,
ZIP/Postal Code
TW5 9ER
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Leicester
ZIP/Postal Code
LE5 4PW
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Nantwich
ZIP/Postal Code
CW5 5NX
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Rotherham
ZIP/Postal Code
S651DA
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Sandbach
ZIP/Postal Code
CW11 1EQ
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Soham
ZIP/Postal Code
CB7 5JD
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Swansea
ZIP/Postal Code
SA2 8PP
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Taunton
ZIP/Postal Code
TA1 5DA
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Truro
ZIP/Postal Code
TR1 3LJ
Country
United Kingdom
Individual Site Status
Active, not recruiting
Facility Name
Novo Nordisk Investigational Site
City
Wellingborough
ZIP/Postal Code
NN8 4RW
Country
United Kingdom
Individual Site Status
Active, not recruiting
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
"According to the Novo Nordisk disclosure commitment on novonordisk-trials.com"
IPD Sharing URL
http://novonordisk-trials.com
Learn more about this trial
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
We'll reach out to this number within 24 hrs